IMFINZI 120 mg/2.4mL

IMFINZI 120 mg/2.4mL is a solution for injection containing durvalumab, used in cancer treatment. This intravenous medication is designed to support immune system function. Learn more about its uses and effects.

IMFINZI 120 mg/2.4mL is primarily used in cancer therapy, specifically for certain types of tumors. Durvalumab, the active ingredient, works by enhancing the body's immune response to help fight cancer cells. This medication is often prescribed as part of a broader treatment plan, including what is durvalumab used for in advanced cancer stages.

Common effects of IMFINZI 120 mg/2.4mL may include fatigue, nausea, and skin reactions at the injection site. Some patients might experience changes in appetite or shortness of breath. These effects can vary from person to person, and it's important to discuss any concerns with a healthcare provider.

IMFINZI 120 mg/2.4mL should be handled with care, following proper storage and administration guidelines. It is crucial to use this medication under the supervision of a healthcare professional. Patients should inform their doctor about any existing medical conditions or allergies before starting treatment.

IMFINZI 120 mg/2.4mL may interact with other medications, including those that affect the immune system. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain supplements may also impact the effectiveness of this treatment.